Rapamycin and its role in aging
Recent research indicates rapamycin to be the only drug that improves mammalian longevity consistently. As recently as 2009, researchers believed …
Rapamycin: mTOR, autophagy and treating mTOR syndrome
Book that examines rapamycin and its role in slowing aging and increasing healthspan fully revised for second edition. Ross Pelton, …
Continue reading “Rapamycin: mTOR, autophagy and treating mTOR syndrome”
Rapamycin – the most promising life extension drug?
New book explores rapamycin, mTOR, autophagy and treating mTOR Syndrome to understand cellular biochemistry, health – and the aging process. …
Continue reading “Rapamycin – the most promising life extension drug?”
Antiaging drug rapamycin might only benefit females, new research shows
Studies in fruit flies suggest women could age differently from men. Researchers from University College London and the Max Planck …
Continue reading “Antiaging drug rapamycin might only benefit females, new research shows”
Brian Kennedy – validating aging interventions and why rapamycin is the gold standard
Dr Brian Kennedy explains why verifying longevity interventions work is key and why the transition to human trials is so …
Impact of metformin, resveratrol and rapamycin on mouse liver proteome
Research shows that diet and macronutrients can influence the cellular machinery – effects can be dampened by three drugs: metformin, …
Continue reading “Impact of metformin, resveratrol and rapamycin on mouse liver proteome”
Johnson & Johnson bags rapamycin analog biotech Anakuria
Phase 1-ready program targeting mTORC1 to be pursued for potential use in polycystic kidney disease and other indications. Privately held …
Continue reading “Johnson & Johnson bags rapamycin analog biotech Anakuria”
Longevity leaders call for trials of rapamycin to treat COVID-19
Lancet commentary calls for immediate large-scale clinical trials of rapamycin and rapalogs, with geroprotective consequences. In March last year, as …
Continue reading “Longevity leaders call for trials of rapamycin to treat COVID-19”
AgelessRx and funding an IRB-approved rapamycin trial
Rapamycin could be the PEARL in the Longevity oyster as new human trial seeks funding. AgelessRx is a platform that …
Continue reading “AgelessRx and funding an IRB-approved rapamycin trial”
